Effects of angiotensin receptor blockers (ARBs) on clinical outcomes of patients with hypertension and COVID-19: A 7-month follow-up cohort study

Azar Hadadi ¹ , Sina Kazemian ² , Mahan Shafie ^3,4, Arezoo Ahmadi ⁵, Abbas Soleimani ⁶, Haleh Ashraf ^2,7 *

Cited by CrossRef: 0

1- Kelleni M. Angiotensin receptor blockers could be superior to angiotensin-converting enzyme inhibitors in COVID-19 management: the potential role of bradykinin. Ir J Med Sci. 2024;193(4):2077 [Crossref]

Platinum Open Access

This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website and open access repositories such as PubMed Central. All related costs for processing of the manuscripts are sponsored by Tabriz University of Medical Sciences.

Indexing Info